Special Report: A Look Behind Hepatitis C Patent Challenges Worldwide 15/11/2017 by Tatum Anderson for Intellectual Property Watch 2 Comments A case at the High Court in India set for 15 December could decide whether a patent on some of the most important drugs to fight hepatitis C should be removed. It is one of many attempts to challenge patents on hepatitis C drugs in various countries around the world and serves as an opportunity to learn more about the group leading the legal case.
‘Damaging’ Provisions On IP Dropped From TPP Agreement, MSF Says 15/11/2017 by William New, Intellectual Property Watch Leave a Comment Trade ministers negotiating the Trans-Pacific Partnership (TPP) without the United States have dropped many problematic provisions related to intellectual property and health, Médicins Sans Frontières (MSF, Doctors Without Borders) reported today. Also removed from the agreement appears to be the investor-state dispute settlement provisions, according to a source.
USPTO’s Revised Patent Fee Schedule Raises Price Of IPR Process 14/11/2017 by Intellectual Property Watch 1 Comment The United States Patent and Trademark Office (USPTO) today issued changes to some patent fees, including increases in certain areas, including the cost of using the inter partes review process. Following feedback from users, the office went with some proposed increases, while keeping others at existing levels despite proposals to increase them, it said.
US Congress Members Signal Move To Block Allergan Patent Deal With Tribe 14/11/2017 by William New, Intellectual Property Watch Leave a Comment Members of a US congressional subcommittee on intellectual property held a hearing last week that appeared aimed at finding ways to stop companies from “renting” the sovereignty of Native American tribes in order to avoid a process that can lead to the invalidation of patents. Elected officials called a deal between Allergan pharmaceutical company and a northeastern tribe a “sham” and a “mockery”, and signalled the start of the legislative procedure to prevent such deals.
Next Global Congress On IP And The Public Interest 13/11/2017 by Intellectual Property Watch Leave a Comment American University Washington College of Law (AUWCL) Program on Information Justice and Intellectual Property has announced the hosting of Fifth Global Congress on Intellectual Property and the Public Interest, from 27-29 September 2018. And it is now actively seeking sponsors, partners and expressions of interest.
Geneva Buzzing With Ideas And Events For International Entrepreneurship Week 09/11/2017 by Intellectual Property Watch Leave a Comment A weeklong event next week has been co-organised and sponsored by a number of Geneva actors, such as the World Intellectual Property Organization, the European Organization for Nuclear Research (CERN), and the University of Geneva, as well as lesser known groups and projects, to celebrate the international week of entrepreneurship.
How Solid IP Security Policy Could Have Prevented The Waymo vs. Uber Legal Debacle 08/11/2017 by Bruce Gain for Intellectual Property Watch Leave a Comment Waymo likely could have avoided a lawsuit against Uber over driverless car technology if it had an effective policy to prevent trade theft by its employees, legal and security experts say.
Custom Built Software And The IP Law – What You Need To Know 07/11/2017 by Guest contributor for Intellectual Property Watch 2 Comments The practice of building custom software is alive and well despite the emergence of tons of ready to use offline and online business apps. Businesses build custom software for various reasons. Some are unsatisfied by solutions available on the market, others need very specific features or overall functionality, security and privacy concerns are another major driver of tailored software development. The process of building custom software involves five basic stages, if you stick to traditional software development workflow, or an indefinite number of iterations under agile development method. Both approaches, however, include various scenarios in which intellectual property rights are involved, writes Jorge Sagastume.
Hepatitis C Buyers’ Clubs Grow Worldwide As A Way To Obtain Affordable Treatment 07/11/2017 by Tatum Anderson for Intellectual Property Watch Leave a Comment Hidden amongst the thousands of Facebook pages given over to holiday snaps and gossip are groups of patients who have hepatitis C, a disease that affects more than 70 million worldwide and kills around 400,000 people a year. But importantly, these groups of patients from Russia to Australia have got together to help each other import a relatively new class of drug that is able to cure most of the patients who take it.
Uganda Parliament Passes Bill To Promote Use Of Genetically Modified Materials, Biotech 03/11/2017 by Hillary Muheebwa for Intellectual Property Watch 2 Comments KAMPALA, Uganda — Several genetically modified crops that are more resilient to drought, flooding, saline or acid soils and temperature extremes resulting from climate change are already being researched in Uganda and are in advanced stages. The enactment of an enabling law, the Uganda National Biosafety Bill 2017, is intended to enhance the development of modern biotechnology.